Statutory Instruments
2026 No. 702
NATIONAL HEALTH SERVICE, ENGLAND
The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2026
Made
at 9.47 a.m. on 29th June 2026
Laid before Parliament
at 3.30 p.m. on 29th June 2026
Coming into force
20th July 2026
The Secretary of State for Health and Social Care makes the following Regulations in exercise of the powers conferred by sections 164(8A)(a), (8B)(b) and (8D) and 272(7) and (8) of the National Health Service Act 2006(1).
Citation, commencement, extent and application
1.—(1) These Regulations may be cited as the National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2026.
(2) These Regulations come into force on 20th July 2026.
(3) These Regulations extend to England and Wales and apply to England only(2).
Amendment to regulation 91A of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013
2.—(1) Regulation 91A of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 (zero or nominal product reimbursement for vaccines and antivirals)(3) is amended as follows.
(2) In paragraph (2)—
(a)omit “or” at the end of sub-paragraph (ae); and
(b)after sub-paragraph (ae), insert—
“(af)a drug or medicine which is used for vaccinating or immunising people against meningococcal disease caused by—
(i)Neisseria meningitidis groups A, C, W and Y bacteria, or
(ii)Neisseria meningitidis group B bacteria,
if the conditions set out in paragraph (3) are satisfied;
(ag)a drug or medicine which is used for vaccinating or immunising people against tetanus, diphtheria and polio, if the conditions set out in paragraph (3) are satisfied; or”.
(3) In paragraph (3A), for “to (ae)” substitute “to (ag)”.
Signed by authority of the Secretary of State for Health and Social Care
Stephen Kinnock
Minister of State
Department of Health and Social Care
at 9.47 a.m. on 29th June 2026
2006 c. 41. In section 164, subsections (8A) to (8E) were inserted by the Health Service Medical Supplies (Costs) Act 2017 (c. 23), section 1, and subsections (8A) and (8D) were thereafter amended by the Health and Care Act 2022 (c. 31), section 161(1)(a) to (c). See section 275(1) of the National Health Service Act 2006 for the meanings given to “prescribed” and “regulations” which are relevant to the powers being exercised.
See section 271(1) of the National Health Service Act 2006, by virtue of which the functions of the Secretary of State being exercised in the making of these Regulations are exercisable only in relation to England.
Inserted by S.I. 2022/930. Relevant amending instruments are S.I. 2024/838, 2024/894, 2025/636 and 2025/989.